Literature DB >> 17679259

Aortic valve replacement for aortic regurgitation in a patient with antiphospholipid antibody syndrome.

Nozomu Sasahashi1, Hisao Harada, Yoshiaki Saji, Akira Marui, Takeshi Nishina, Masashi Komeda.   

Abstract

Cardiac manifestations of antiphospholipid antibody syndrome (APLS) comprise a major complication. Herein we report our surgical treatment of aortic regurgitation in a patient with APLS. A 61-year-old woman was referred to our hospital with symptoms of congestive heart failure. Systemic lupus erythematosus had been diagnosed at the age of 36, and immunosuppressive therapy has been continuously performed. APLS was also diagnosed at the age of 55, after which cardiomegaly was noted on chest radiographs and aortic regurgitation was evident on echocardiography. Although immunosuppressive therapy had been continued, cardiac symptoms began to develop. With a presumed diagnosis of valvular disease associated with autoimmune disease, the aortic valve was replaced with a bioprosthesis. Noninfective endocarditis was confirmed in the excised specimen and was likely involved in APLS. The patient was discharged on postoperative day 26 without complications.

Entities:  

Mesh:

Year:  2007        PMID: 17679259     DOI: 10.1007/s11748-007-0128-4

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  9 in total

1.  Antiphospholipid antibodies and the heart. Lessons and pitfalls for the cardiologist.

Authors:  R A Asherson; R Cervera
Journal:  Circulation       Date:  1991-08       Impact factor: 29.690

2.  Secondary mitral valve replacement in antiphospholipid syndrome and chronic renal failure.

Authors:  Y Kato; F Isobe; Y Sasaki; H Kumano; K Nagamachi; H Arimoto
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-12

3.  Does antiphospholipid antibody syndrome affect bioprosthetic heart valve? Midterm echocardiographic report.

Authors:  Shunei Saito; Hiroshi Ikeguchi; Harumitsu Yamamoto; Akira Koike; Kazuo Yamaguchi; Eiji Takeuchi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2005-01

4.  Aortic regurgitation progressing to aortic stenosis in antiphospholipid syndrome.

Authors:  A Escalante; F O Tio; G L Freeman
Journal:  Am Heart J       Date:  1995-10       Impact factor: 4.749

5.  Aortic valve replacement for aortic regurgitation in a patient with primary antiphospholipid syndrome.

Authors:  K Matsuyama; Y Ueda; H Ogino; T Sugita; K Matsubayashi; T Nomoto; S Yoshimura; T Yoshioka
Journal:  Jpn Circ J       Date:  1999-09

6.  Thrombosis of aortic valve homograft associated with lupus anticoagulant antibodies.

Authors:  Philippe Unger; Danièle Plein; Olivier Pradier; Jean-Louis LeClerc
Journal:  Ann Thorac Surg       Date:  2004-01       Impact factor: 4.330

7.  Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery.

Authors:  Yackov Berkun; Amir Elami; Karen Meir; Dror Mevorach; Yaakov Naparstek
Journal:  J Thorac Cardiovasc Surg       Date:  2004-02       Impact factor: 5.209

Review 8.  Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome.

Authors:  M Hojnik; J George; L Ziporen; Y Shoenfeld
Journal:  Circulation       Date:  1996-04-15       Impact factor: 29.690

Review 9.  Cardiac manifestations of the antiphospholipid syndrome.

Authors:  S D Kaplan; E K Chartash; R A Pizzarello; R A Furie
Journal:  Am Heart J       Date:  1992-11       Impact factor: 4.749

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.